Evidence map›Paper›PMID 40289768›Full record

ArticleGlia2025

Astroglial CB

Yamuna Mariani, Tommaso Dalla-Tor, Tommaso Garavaldi, Francisca Julio-Kalajzić, Doriane Gisquet, Paula Gomez-Sotres, Astrid Cannich, Giuditta Gambino, Filippo Drago, Roman Serrat and 6 more

Abstract read
In one paragraph

Article in Glia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Sex-specific role of microglia in ΔNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Yamuna MarianiINSERM, U1215 Neurocentre Magendie, Université de Bordeaux, Bordeaux, France.
Tommaso Dalla-TorINSERM, U1215 Neurocentre Magendie, Université de Bordeaux, Bordeaux, France.
Tommaso GaravaldiINSERM, U1215 Neurocentre Magendie, Université de Bordeaux, Bordeaux, France.ORCID 0009-0007-8983-5651
Francisca Julio-KalajzićINSERM, U1215 Neurocentre Magendie, Université de Bordeaux, Bordeaux, France.
Doriane GisquetINSERM, U1215 Neurocentre Magendie, Université de Bordeaux, Bordeaux, France.
Paula Gomez-SotresINSERM, U1215 Neurocentre Magendie, Université de Bordeaux, Bordeaux, France.ORCID 0000-0002-1755-673X
Astrid CannichINSERM, U1215 Neurocentre Magendie, Université de Bordeaux, Bordeaux, France.
Giuditta GambinoDepartment of Biomedicine, Neuroscience and Advanced Diagnostics (BIND), University of Palermo, Palermo, Italy.ORCID 0000-0001-8155-2808
Filippo DragoDepartment of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania, Catania, Italy.
Roman SerratINSERM, U1215 Neurocentre Magendie, Université de Bordeaux, Bordeaux, France.ORCID 0000-0001-5530-2135
Imane HurelINSERM, U1215 Neurocentre Magendie, Université de Bordeaux, Bordeaux, France.ORCID 0000-0001-7392-6427
Francis ChaouloffINSERM, U1215 Neurocentre Magendie, Université de Bordeaux, Bordeaux, France.ORCID 0000-0001-9036-4067
Sandrine PouvreauINSERM, U1215 Neurocentre Magendie, Université de Bordeaux, Bordeaux, France.ORCID 0000-0002-0895-0030
Luigi BellocchioINSERM, U1215 Neurocentre Magendie, Université de Bordeaux, Bordeaux, France.ORCID 0000-0001-7774-3935
Giovanni MarsicanoINSERM, U1215 Neurocentre Magendie, Université de Bordeaux, Bordeaux, France.ORCID 0000-0003-3804-1951
Ana CoveloINSERM, U1215 Neurocentre Magendie, Université de Bordeaux, Bordeaux, France.ORCID 0000-0002-9121-8632

Funding

Agence Nationale de la Recherche LABEX BRAIN ANR-10-LABX-43Agencia Estatal de Investigación RYC2022-035546-IBrain and Behavior Research FoundationEuropean Research Council ERC-2010-StG-260515European Research Council ERC-2014-PoC-640923European Research Council ERC-2017-AdG-786467Foundation pour la recherche medicale DRM20101220445Human Frontier Science Program LT 000827/2019-L3Institut National de la Santé et de la Recherche MédicaleUniversité de Bordeaux
6 · The paper itself

Abstract

The Nucleus Accumbens (NAc) is a critical brain region for the effects of psychostimulant drugs. Type-1 cannabinoid receptors (CB

Indexed as

AmphetamineAstrocytesCentral Nervous System StimulantsNeuronal PlasticityNucleus AccumbensReceptor, Cannabinoid, CB1Sex CharacteristicsSynapsesAnimalsFemaleMaleMiceMice, Inbred C57BLMice, KnockoutAmphetamineCentral Nervous System StimulantsReceptor, Cannabinoid, CB1adenosineamphetamineastrocytesCB1sex differencesspike‐timing‐dependent plasticity

Identifiers

PMID40289768
PMCPMC12185978

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.